Efficacy and safety of repaglinide in combination with metformin in Type 2 diabetes inadequately controlled with oral anti-diabetic drugs

被引:0
|
作者
Li, Guang-wei [1 ]
Jia, Wei-ping [2 ]
Pan, Chang-yu [3 ]
Guo, Xiao-hui [4 ]
Zou, Da-jin [5 ]
机构
[1] Peking China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] Shanghai 6 People Hosp, Dept Endocrinol, Shanghai, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China
[4] Peking Univ, Hosp 1, Dept Endocrinol, Beijing, Peoples R China
[5] Shanghai Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China
关键词
D O I
10.1016/S0168-8227(08)70727-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S32 / S33
页数:2
相关论文
共 50 条
  • [1] Efficacy and safety of repaglinide and metformin combination therapy compared to repaglinide monotherapy in Chinese oral anti-diabetic drug (OAD) naive type 2 diabetic patients
    Wang, W.
    Ning, G.
    Su, Q.
    Liu, J.
    Bu, R.
    [J]. DIABETOLOGIA, 2010, 53
  • [2] Oral anti-diabetic drugs for the prevention of Type 2 diabetes
    Phung, O. J.
    Sood, N. A.
    Sill, B. E.
    Coleman, C. I.
    [J]. DIABETIC MEDICINE, 2011, 28 (08) : 948 - 964
  • [3] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
    Magner, J
    Taylor, T
    Krol, A
    Rosenstock, J
    [J]. DIABETOLOGIA, 1998, 41 : A231 - A231
  • [4] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, J
    Magner, J
    Krol, A
    Taylor, T
    [J]. DIABETES, 1998, 47 : A351 - A351
  • [5] Efficacy and Safety of Linagliptin in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy
    Taskinen, Marja-Riitta
    Rosenstock, Julio
    Tamminen, Ilkka
    Kubiak, Rene
    Patel, Sanjay
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    [J]. DIABETES, 2010, 59 : A158 - A158
  • [6] Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
    Lukashevich, V.
    Prato, S. D.
    Araga, M.
    Kothny, W.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 403 - 409
  • [7] Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin
    Al Omari, Mousa
    Khader, Yousef
    Dauod, Ali Shakir
    Yonis, Othman Ahmed Beni
    Khassawneh, Adi Harbi Mohammad
    [J]. JOURNAL OF DRUG ASSESSMENT, 2016, 5 (01) : 29 - 33
  • [8] Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea
    Gao, Yan
    Yoon, Kun Ho
    Chuang, Lee-Ming
    Mohan, Viswanathan
    Ning, Guang
    Shah, Sanjiv
    Jang, Hak Chul
    Wu, Ta-Jen
    Johns, Don
    Northrup, Justin
    Brodows, Robert
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 69 - 76
  • [9] Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes
    Raskin, P.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (12): : 1167 - 1177
  • [10] Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment In Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: A Trial of Early Combination Treatment in Diabetes (TREND)
    Ji, Linong
    Lu, Juming
    Hong, Tianpei
    Yang, Wenying
    Zou, Dajin
    Li, Yanbing
    [J]. DIABETES, 2013, 62 : A672 - A672